NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

1) KOL support. I personally have been working in the neurology (medical device) world for 20 years. I know first hand how influential some of these neurosurgeons are and how niche of a community this is. For example, I have followed Dr. Ashkan’s work with PD over many years. He is arguably an even bigger rockstar in that space. Also, I know one medical doctor in Chicago that was involved in DCVAX-L ph 3 trial at their center (helping with coordination during the last couple of years). I will leave it at that.

2) I am hoping that big pharma comes along as a partner at a higher valuation in a year or so.

3) Age of the management. You would think they would want to cash out in a couple of years, if not sooner. I have been personally involved in an M&A where our former company was acquired by one of the top 10 medical device companies. I visited couple of our KOL sites along with the M&A team as part of their DD process. Also, I was part of the executive team and fairly close to the founders. So I have a decent understanding of how these things play out and some of the triggers.

4) Playing on house money. Although opportunity cost applies on house money too!

Nevertheless it’s painful to see how this management treats the shareholders. Ethics of the management, sketchy history over the years, and the pumpers they deploy is what concerns me a lot because it’s extremely difficult to put any trust. So 2 & 3 is a bit of a gamble.